| scholarly article | Q13442814 |
| P2093 | author name string | P M Bell | |
| R A Rizza | |||
| I Hansen | |||
| H M Marsh | |||
| R G Firth | |||
| P2860 | cites work | Some basic dificiencies of the plethysmographic method and possibilities of avoiding them | Q78584108 |
| The glucose paradox. Is glucose a substrate for liver metabolism? | Q28267552 | ||
| Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion | Q33821886 | ||
| Glucose turnover and disposal in maturity-onset diabetes | Q34514921 | ||
| Influence of hyperglycemia on insulin's in vivo effects in type II diabetes | Q34605059 | ||
| Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy | Q34614746 | ||
| ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE | Q35505149 | ||
| Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus | Q37004187 | ||
| Effect of glucagon on glucose production during insulin deficiency in the dog | Q37031782 | ||
| Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes | Q37038173 | ||
| Increased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes | Q37686773 | ||
| Glucose load diverts hepatic gluconeogenic product from glucose to glycogen in vivo | Q39621682 | ||
| A Molecular Order in the Synthesis and Degradation of Glycogen in the Liver | Q40258955 | ||
| Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus | Q40326240 | ||
| Normal alanine-glucose relationships and their changes in diabetic patients before and after insulin treatment | Q41624431 | ||
| Influence of Oral Glucose Ingestion on Splanchnic Glucose and Gluconeogenic Substrate Metabolism in Man | Q41966797 | ||
| Estimation of glucose turnover with stable tracer glucose-1-13C. | Q43850327 | ||
| Measurement of size and turnover rate of body glucose pool by the isotope dilution method | Q47438874 | ||
| The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes. | Q51651477 | ||
| Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. | Q51653371 | ||
| Circulating Alanine Disposal in Diabetes Mellitus | Q51665139 | ||
| Futile Cycles in the Metabolism of Glucose | Q51671663 | ||
| Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? | Q51671984 | ||
| Radioimmunological determination of human C-peptide in serum | Q51672193 | ||
| A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients | Q51677804 | ||
| Glucose dynamics in normal subjects and diabetic patients before and after a glucose load. | Q51690256 | ||
| Initial splanchnic extraction of ingested glucose in normal man. | Q52792774 | ||
| Relationship Between the Basal Glucose Concentration Glucose Tolerance and Forearm Glucose Uptake in Maturity-onset Diabetes | Q54308678 | ||
| Influence of Maturity-onset Diabetes on Splanchnic Glucose Balance After Oral Glucose Ingestion | Q67265138 | ||
| Studies on hepatic glucose cycles in normal and methylprednisolone-treated dogs | Q67542777 | ||
| Forearm Glucose Uptake During the Oral Glucose Tolerance Test in Normal Subjects | Q69542114 | ||
| Glucose uptake and production during the oral glucose tolerance test | Q69848064 | ||
| The disposal of an oral glucose load in healthy subjects. A quantitative study | Q69896265 | ||
| Dose-response characteristics for effects of insulin on production and utilization of glucose in man | Q70157794 | ||
| Correction for the metabolic exchange of 14C for 12C atoms in the pathway of gluconeogenesis in vivo | Q70272626 | ||
| Pathways of carbon flux in gluconeogenesis | Q70272642 | ||
| Sources of carbon in hepatic glycogen synthesis during absorption of an oral glucose load in humans | Q71585328 | ||
| Splanchnic and peripheral disposal of oral glucose in man | Q71763755 | ||
| Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. A direct or an indirect pathway? | Q71766859 | ||
| Importance of the Hematocrit in Interpretation of Blood Sugar | Q72556502 | ||
| BILATERAL DIFFERENCES IN FOREARM BLOOD FLOW AS MEASURED WITH CAPACITANCE PLETHYSMOGRAPH | Q76563914 | ||
| The source of blood samples withdrawn from deep forearm veins via catheters passed upstream from the median cubital vein | Q78283465 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| hyperglycemia | Q271993 | ||
| P304 | page(s) | 1525-1532 | |
| P577 | publication date | 1986-05-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues | |
| P478 | volume | 77 |
| Q41583875 | A Single Day of Excessive Dietary Fat Intake Reduces Whole-Body Insulin Sensitivity: The Metabolic Consequence of Binge Eating. |
| Q38292347 | A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes |
| Q51386060 | A novel surrogate index for hepatic insulin resistance. |
| Q45013706 | Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes |
| Q54174590 | Abnormal transient rise in hepatic glucose production after oral glucose in non-insulin-dependent diabetic subjects |
| Q46229486 | Accuracy and reliability of continuous blood glucose monitor in post-surgical patients |
| Q38009587 | Acute and chronic effects of hyperglycaemia on glucose metabolism |
| Q35711899 | Alterations of glucose metabolism in type 2 diabetes mellitus. An overview |
| Q35824548 | Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans |
| Q34549728 | Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used |
| Q51384660 | Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men. |
| Q44775968 | Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes |
| Q26865069 | Calcineurin inhibition and new-onset diabetes mellitus after transplantation |
| Q45140608 | Calcitonin gene-related peptide-1 (CGRP-1) is a potent regulator of glycogen metabolism in rat skeletal muscle |
| Q38215557 | Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment |
| Q45201531 | Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity |
| Q33889791 | Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus |
| Q33757375 | Clinical implications of amylin and amylin deficiency |
| Q51615494 | Contribution of gluconeogenesis to overall glucose output in diabetic and nondiabetic men. |
| Q40850456 | Control of glycaemia |
| Q33631885 | Control of hepatic gluconeogenesis by the promyelocytic leukemia zinc finger protein |
| Q35180025 | Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats |
| Q24609701 | Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans |
| Q44230857 | Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects |
| Q37359561 | Discriminatory value of alanine aminotransferase for diabetes prediction: the Insulin Resistance Atherosclerosis Study |
| Q51309524 | Diurnal variation in skeletal muscle and liver glycogen in humans with normal health and Type 2 diabetes. |
| Q43572356 | Early insulin release effectively improves glucose tolerance: studies in two rodent models of type 2 diabetes mellitus |
| Q51598296 | Effect of benfluorex on insulin secretion and insulin action in streptozotocin-diabetic rats. |
| Q44163049 | Effect of cholecystokinin-A receptor blockade on postprandial insulinaemia and gastric emptying in humans |
| Q44058300 | Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans |
| Q37355181 | Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance |
| Q44916010 | Effects of chronic systemic insulin delivery on insulin action in dogs |
| Q73384092 | Effects of endothelin-1 and nitric oxide on glucokinase activity in isolated rat hepatocytes |
| Q74081998 | Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans |
| Q36886618 | Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension |
| Q42114314 | Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism |
| Q38592327 | Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition |
| Q51559853 | Ethnicity affects the postprandial regulation of glycogenolysis. |
| Q24561425 | Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus |
| Q72258285 | Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM |
| Q52398131 | Hepatic and extrahepatic insulin action in humans: measurement in the absence of non-steady-state error. |
| Q30466963 | Hepatic glucose metabolism and insulin resistance in NIDDM and obesity |
| Q35214635 | Hepatic glucose metabolism in humans--its role in health and disease |
| Q34361034 | Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis |
| Q35859162 | Hepatic insulin sensitivity in healthy and prediabetic subjects: from a dual- to a single-tracer oral minimal model |
| Q43580290 | Iminosugars: potential inhibitors of liver glycogen phosphorylase |
| Q35516372 | Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs |
| Q47150755 | Impaired hepatic counterregulatory response to insulin-induced hypoglycemia in hepatic denervated pigs |
| Q51604694 | In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment. |
| Q45238638 | Inclusion of low amounts of fructose with an intraportal glucose load increases net hepatic glucose uptake in the presence of relative insulin deficiency in dog. |
| Q51616792 | Increased glucose carbon recycling in severely insulin deficient type 1 (insulin-dependent) diabetic subjects. |
| Q30796726 | Increased hepatic fructose 2,6-bisphosphate after an oral glucose load does not affect gluconeogenesis |
| Q51568464 | Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat model. |
| Q35195049 | Increased nutrient sensitivity and plasma concentrations of enteral hormones during duodenal nutrient infusion in functional dyspepsia |
| Q41166028 | Insulin resistance in non-insulin-dependent diabetes mellitus. A review |
| Q39532297 | Insulin treatment of non-insulin-dependent diabetes mellitus |
| Q39788737 | Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus |
| Q37444351 | Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus? |
| Q54385381 | JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates impaired glucose and lipid metabolism in Zucker diabetic fatty rats. |
| Q51564709 | JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats. |
| Q46616695 | Marked differences in the IGF system that are associated with migration in comparable populations of Gujaratis living in Sandwell, UK, and Gujarat, India. |
| Q98164482 | Mathematical model of blood glucose dynamics by emulating the pathophysiology of glucose metabolism in type 2 diabetes mellitus |
| Q44271320 | Mechanism of growth hormone-induced postprandial carbohydrate intolerance in humans |
| Q35818094 | Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism |
| Q46654997 | Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes |
| Q46019997 | Men Are from Mars, Women Are from Venus: Sex Differences in Insulin Action and Secretion. |
| Q33907730 | Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans |
| Q40303746 | Metabolic handling of orally administered glucose in cirrhosis |
| Q41603308 | Metformin |
| Q36764049 | Modeling hepatic insulin sensitivity during a meal: validation against the euglycemic hyperinsulinemic clamp |
| Q38628354 | Molecular pathophysiology of hepatic glucose production |
| Q51613996 | On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. |
| Q39400642 | Oral Insulin Delivery in a Physiologic Context: Review |
| Q56341675 | Paradigm shifts in Nocturnal Glucose Control in Type 2 Diabetes |
| Q38241788 | Parenteral nutrition in patients with diabetes mellitus: theoretical and practical considerations |
| Q34237562 | Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy |
| Q44051684 | Pathogenesis of hyperglycaemia in type 2 diabetes |
| Q54049618 | Pathogenesis of non-insulin-dependent (type II) diabetes mellitus (NIDDM) - genetic predisposition and metabolic abnormalities. |
| Q35787142 | Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview |
| Q44244726 | Pathways for glucose disposal after meal ingestion in humans |
| Q44737309 | Peripheral tissue glucose uptake is not reduced after an oral glucose load in Southern Italian subjects at risk of developing non-insulin-dependent diabetes mellitus |
| Q36842541 | Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content |
| Q36560594 | Portal vein glucose entry triggers a coordinated cellular response that potentiates hepatic glucose uptake and storage in normal but not high-fat/high-fructose-fed dogs |
| Q50186670 | Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes. |
| Q30939844 | Pramlintide for the treatment of insulin-requiring diabetes mellitus: rationale and review of clinical data |
| Q36715658 | Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1. |
| Q35583720 | Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load |
| Q41437595 | RNA sequencing of db/db mice liver identifies lncRNA H19 as a key regulator of gluconeogenesis and hepatic glucose output |
| Q37384513 | Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus |
| Q34787063 | Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant? |
| Q46199992 | Regulation of hepatic metabolism by enteral delivery of nutrients |
| Q43268882 | Regulation of liver glucokinase activity in rats with fructose-induced insulin resistance and impaired glucose and lipid metabolism |
| Q34556238 | Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes |
| Q35176134 | Resistance to Injection: 1991 RD Lawrence Lecture |
| Q37023109 | Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats |
| Q43852616 | Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis |
| Q33910469 | Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production |
| Q35588419 | Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load |
| Q37226854 | The Liver and Glycogen Metabolism |
| Q39650599 | The biochemistry of diabetes |
| Q44513024 | The effect of nateglinide taken with food on gastric emptying rates in healthy subjects |
| Q69908961 | The effects of hyperglycaemia on isotopic measurement of glucose utilisation using [2(3)H], [3(3)H] and [6(14)C] glucose in patients with type 1 (insulin-dependent) diabetes mellitus |
| Q34201786 | The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues |
| Q41499323 | The emerging role of oestrogen-related receptor γ as a regulator of energy metabolism |
| Q38419053 | The forgotten role of glucose effectiveness in the regulation of glucose tolerance |
| Q40521981 | The fourth musketeer--from Alexandre Dumas to Claude Bernard |
| Q39700102 | The measurement of metabolite exchange across muscle beds |
| Q38247935 | The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents. |
| Q35214630 | Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions |
| Q35902915 | Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11β-hydroxysteroid dehydrogenase 1 |
| Q44251613 | Use of a novel triple-tracer approach to assess postprandial glucose metabolism |
| Q36977016 | Use of labeled oral minimal model to measure hepatic insulin sensitivity |
| Q38586629 | What is a normal blood glucose? |
Search more.